Clinical trial
Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy (Title in France: Compensation of Vision With the Intelligent Retinal Implant System (IRIS V1) in Patients With Retinal Dystrophy)
NCT01864486 is registered in ClinicalTrials.gov with Science Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy (Title in France: Compensation of Vision With the Intelligent Retinal Implant System (IRIS V1) in Patients With Retinal Dystrophy)
- Lead sponsor
- Science Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2013
- Completion date
- October 13, 2017
- Enrollment
- 20 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
choroideremia, cone rod dystrophy, retinitis pigmentosa